Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Conditions
Interventions
Intervention1: centhroman in mastalgia: Centchroman given at dose of 30mcg per oral thrice/week for 4 weeks followed by 2/week for next 4 weeks followed by 1/week for next 4 weeks.
Control Interventio
Sponsors
Uttar Pradesh University of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: All women with mastalgia with VAS score =3 lasting for more than 5-7 days per cycle were included after signing a consent form.
Exclusion criteria
Exclusion criteria: • Patients with polycystic ovarian diseases and uterine cervical hyperplasia. • First six months of Lactation and pregnancy • Patients who were not giving consent. • Past history of breast carcinoma or family history of breast carcinoma • Patient who were planning for pregnancy . • Women suspected or diagnosed of malignancy • Recent history of jaundice or hepatic impairment. • Severe allergic states. • History of thrombosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptomatic relief from cyclical mastalgia.Timepoint: Outcome will be assessed at 4,8,12 and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in fibroadenosis as well as reduction in size of fibroadenoma.Timepoint: Outcome will be assessed at 4,8,12 & 24 weeks | — |
Countries
India
Contacts
Public ContactDharmendra Tarkar
UPUMS SAIFAI ETAWAH
Outcome results
None listed